10x Genomics, Inc.
TXGNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for TXG. That does not mean none is planned.
Get an email about TXG's next catalysts
Track 10x Genomics (TXG) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 1 past
No catalysts found.
Market Overview
Stock performance and key metrics
10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.
WebsiteNo drugs found in this phase.
Frequently asked questions
When is 10x Genomics, Inc.'s next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for 10x Genomics, Inc. (TXG) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track TXG biotech catalysts?β
Add TXG to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow 10x Genomics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
